Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA

  • PDF / 1,639,336 Bytes
  • 2 Pages / 595.276 x 790.866 pts Page_size
  • 102 Downloads / 141 Views

DOWNLOAD

REPORT

CORRECTION

Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology Noraisyah Mohd Sani, MSc, B. Pharmacy (Hon)1 · Neil McAuslane, PhD2 · Siti Hidayah Kasbon, MSc, B. Pharmacy (Hon)1 · Rosilawati Ahmad, MSc, B. Pharmacy (Hon)1 · Faridah Aryani Md. Yusof, PhD, MSc, B. Pharmacy (Hon)1 · Prisha Patel, MSc2 Published online: 9 April 2020 © The Drug Information Association, Inc 2020

Correction to: Therapeutic Innovation & Regulatory Science https​://doi.org/10.1007/s4344​1-020-00140​-4

The authors have revised Fig. 1. The revised Fig. 1 is presented below.

The original article can be found online at https​://doi.org/10.1007/ s4344​1-020-00140​-4. * Neil McAuslane [email protected] 1



National Pharmaceutical Regulatory Agency, Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia



Centre for Innovation in Regulatory Science (CIRS), 160 Blackfriars Road, London SE18EZ, UK

2

13

Vol.:(0123456789)

1226

Figure 1.  NPRA Review Process.

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

13

Therapeutic Innovation & Regulatory Science (2020) 54:1225–1226

Data Loading...

Recommend Documents
An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

135 78 1MB

Using an Expert Panel to Validate the Malaysian SMEs-Software Process Improvement Model (MSME-SPI)

151 101 418KB

Biosimilars in Malaysia: Regulatory Framework, Approved Products, and Adverse Effects

181 21 765KB

Correction to: Exposure to catastrophe risk and use of reinsurance: an empirical evaluation for the U.S.

158 34 331KB

Correction to: Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition i

148 49 349KB

The Regulatory Environment for the New Millennium

190 78 891KB

Increased Stress Resistance of the Offspring Egg Cross Chickens when Using Biologically Active Substances before Hatchin

132 49 179KB

The Regulatory Approval Process of Animal Drugs

151 43 473KB

Performance Evaluation on the Smartness of Malaysian Timber

156 27 27MB

The OPERA experiment

154 98 629KB

An Experimental Model of Regulatory Science in Asia: Center for Drug Evaluation in Taiwan

130 28 4MB

The Regulatory Evaluation of Vaccines for Human Use

140 57 644KB